# Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)

> **NCT00989612** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 100 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza investigational vaccine GSK2340274A

## Key facts

- **NCT ID:** NCT00989612
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-01
- **Primary completion:** 2010-04-19
- **Final completion:** 2010-04-19
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989612, "Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00989612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*